Regarding initial presentation, unlike what is well established in patients with AML, where FLT3 mutations are associated with elevated leukocyte counts at diagnosis (22, 23, 59), none of the patients with FLT3 mutations in our study presented with hyperleukocytosis. This evidence concerns the gene FLT3 and acute myeloid leukemia.